-DOCSTART- -X- O
Although -X- _ O
members -X- _ O
of -X- _ O
the -X- _ O
Flaviviridae -X- _ O
display -X- _ O
high -X- _ O
incidence -X- _ O
, -X- _ O
morbidity -X- _ O
, -X- _ O
and -X- _ O
mortality -X- _ O
rates -X- _ O
, -X- _ O
the -X- _ O
development -X- _ O
of -X- _ O
specific -X- _ O
antiviral -X- _ O
drugs -X- _ O
for -X- _ O
each -X- _ O
virus -X- _ O
is -X- _ O
unlikely. -X- _ O
Cyclophilins -X- _ O
, -X- _ O
a -X- _ O
family -X- _ O
of -X- _ O
host -X- _ O
peptidyl-prolyl -X- _ O
cis-trans -X- _ O
isomerases -X- _ O
( -X- _ O
PPIases -X- _ O
) -X- _ O
, -X- _ O
play -X- _ O
a -X- _ O
pivotal -X- _ O
role -X- _ O
in -X- _ O
the -X- _ O
life -X- _ O
cycles -X- _ O
of -X- _ O
many -X- _ O
viruses -X- _ O
and -X- _ O
therefore -X- _ O
represent -X- _ O
an -X- _ O
attractive -X- _ O
target -X- _ O
for -X- _ O
broad-spectrum -X- _ O
antiviral -X- _ O
development. -X- _ O
We -X- _ O
report -X- _ O
here -X- _ O
the -X- _ O
pangenotypic -X- _ B-Intervention
anti-hepatitis -X- _ I-Intervention
C -X- _ I-Intervention
virus -X- _ I-Intervention
( -X- _ I-Intervention
HCV -X- _ I-Intervention
) -X- _ I-Intervention
activity -X- _ I-Intervention
of -X- _ I-Intervention
a -X- _ I-Intervention
small-molecule -X- _ I-Intervention
cyclophilin -X- _ I-Intervention
inhibitor -X- _ I-Intervention
( -X- _ I-Intervention
SMCypI -X- _ I-Intervention
) -X- _ I-Intervention
. -X- _ O
Mechanistic -X- _ O
and -X- _ O
modeling -X- _ O
studies -X- _ O
revealed -X- _ O
that -X- _ O
the -X- _ O
SMCypI -X- _ B-Intervention
bound -X- _ B-Outcome
to -X- _ I-Outcome
cyclophilin -X- _ I-Outcome
A -X- _ I-Outcome
in -X- _ I-Outcome
competition -X- _ I-Outcome
with -X- _ I-Outcome
cyclosporine -X- _ I-Outcome
( -X- _ I-Outcome
CsA -X- _ I-Outcome
) -X- _ I-Outcome
, -X- _ I-Outcome
inhibited -X- _ I-Outcome
its -X- _ I-Outcome
PPIase -X- _ I-Outcome
activity -X- _ I-Outcome
, -X- _ I-Outcome
and -X- _ I-Outcome
disrupted -X- _ I-Outcome
the -X- _ I-Outcome
CypA- -X- _ I-Outcome
nonstructural -X- _ I-Outcome
protein -X- _ I-Outcome
5A -X- _ I-Outcome
( -X- _ I-Outcome
NS5A -X- _ I-Outcome
) -X- _ I-Outcome
interaction. -X- _ I-Outcome
Resistance -X- _ O
selection -X- _ O
showed -X- _ O
that -X- _ O
the -X- _ O
lead -X- _ B-Outcome
SMCypI -X- _ I-Outcome
hardly -X- _ I-Outcome
selected -X- _ I-Outcome
amino -X- _ I-Outcome
acid -X- _ I-Outcome
substitutions -X- _ I-Outcome
conferring -X- _ I-Outcome
low-level -X- _ I-Outcome
or -X- _ I-Outcome
no -X- _ I-Outcome
resistance -X- _ I-Outcome
in -X- _ I-Outcome
vitro. -X- _ I-Outcome
Interestingly -X- _ O
, -X- _ O
the -X- _ O
SMCypI -X- _ B-Outcome
selected -X- _ I-Outcome
D320E -X- _ I-Outcome
and -X- _ I-Outcome
Y321H -X- _ I-Outcome
substitutions -X- _ I-Outcome
, -X- _ O
located -X- _ O
in -X- _ O
domain -X- _ O
II -X- _ O
of -X- _ O
the -X- _ O
NS5A -X- _ O
protein. -X- _ O
These -X- _ O
substitutions -X- _ O
were -X- _ O
previously -X- _ O
associated -X- _ O
with -X- _ O
low-level -X- _ O
resistance -X- _ O
to -X- _ O
cyclophilin -X- _ O
inhibitors -X- _ O
such -X- _ O
as -X- _ O
alisporivir. -X- _ O
Finally -X- _ O
, -X- _ O
the -X- _ O
SMCypI -X- _ B-Outcome
inhibited -X- _ I-Outcome
the -X- _ I-Outcome
replication -X- _ I-Outcome
of -X- _ I-Outcome
other -X- _ I-Outcome
members -X- _ I-Outcome
of -X- _ I-Outcome
the -X- _ I-Outcome
Flaviviridae -X- _ I-Outcome
family -X- _ I-Outcome
with -X- _ I-Outcome
higher -X- _ I-Outcome
50 -X- _ I-Outcome
% -X- _ I-Outcome
effective -X- _ I-Outcome
concentrations -X- _ I-Outcome
( -X- _ I-Outcome
EC -X- _ I-Outcome
( -X- _ I-Outcome
50 -X- _ I-Outcome
) -X- _ I-Outcome
s -X- _ I-Outcome
) -X- _ I-Outcome
than -X- _ I-Outcome
for -X- _ I-Outcome
HCV. -X- _ I-Outcome
Thus -X- _ O
, -X- _ O
because -X- _ O
of -X- _ O
its -X- _ O
chemical -X- _ O
plasticity -X- _ O
and -X- _ O
simplicity -X- _ O
of -X- _ O
synthesis -X- _ O
, -X- _ O
our -X- _ O
new -X- _ O
family -X- _ O
of -X- _ O
SMCypIs -X- _ B-Intervention
represents -X- _ O
a -X- _ O
promising -X- _ O
new -X- _ O
class -X- _ O
of -X- _ O
drugs -X- _ O
with -X- _ O
the -X- _ O
potential -X- _ O
for -X- _ O
broad-spectrum -X- _ O
anti- -X- _ O
Flaviviridae -X- _ O
activity -X- _ O
as -X- _ O
well -X- _ O
as -X- _ O
an -X- _ O
invaluable -X- _ O
tool -X- _ O
to -X- _ O
explore -X- _ O
the -X- _ O
role -X- _ O
of -X- _ O
cyclophilins -X- _ O
in -X- _ O
viral -X- _ O
life -X- _ O
cycles -X- _ O
. -X- _ O

